Taiko Pharmaceutical, a company founded on the principles of Independence, Interdependence and Creativity is focused on bringing great happiness to our customers around the world.
Seeking what's needed for a healthy society.
Outstanding R&D capacity is one of the features of Taiko Pharmaceutical. JP wood creosote is the major content of the Seirogan, and Taiko Pharmaceutical has uncovered information on the interrelations between JP wood creosote and the human digestive system from various studies. Moreover, Taiko Pharmaceutical is working together with top researchers worldwide to investigate the treatment effects of low-concentration Chlorine dioxide on infections caused by viruses and bacteria.
The overseas pharmaceutical market expansion capacity based on Seirogan is another feature of Taiko Pharmaceutical. From now on, we will expand our sanitation control business worldwide.